Á¦ 73Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY1) : 2021-11-03±³À°ÀÏÀÚ : 2021-11-03
±³À°Àå¼Ò : ¼¿ï COEX 203È£ ¿Ü
±³À°ÁÖÁ¦ :
Á¦ 73Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ(DAY1)ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : ±èÁöÇü
¿¬¶ôó : 02-573-8190
À̸ÞÀÏ :
urology@urology.or.kr ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 900¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 110,000¿ø
ºñ°í ºÀÁ÷ȸ¿ø: 110,000¿ø/°³¿øȸ¿ø: 110,000¿ø/±ºÀÇ°ü,°øº¸ÀÇ: 66,000¿ø/Àü°øÀÇ: 66,000¿ø/Ÿ°úÀü¹®ÀÇ:120,000¿ø/Ÿ°úÀü¹®ÀÇ(1Àϵî·Ï):88,000¿ø/°£È£»ç: 66,000¿ø/°£È£»ç(1Àϵî·Ï):33,000¿ø/¿¬±¸¿ø:66,000¿ø/Á¦¾àȸ»ç ¹× ÀÇ·á±âȸ»ç: 120,000¿ø *»çÀüµî·Ï ±âÁØ
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-03 D (Room.203) 10:00~10:30 Countermeasures against CCTV Installation in operating room ¹ÚÈ«ÁÖ(°¿øÀÇ´ë)
±³À°½Ã°£ 11-03 D (Room.203) 10:30~11:00 Coping with the trend of institutionlization of physician`s assistant nurse ±èų²(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11-03 D (Room.203) 11:00~11:30 Preparation and completion of appropriate surgical informed consent ¼ÛÇÊÇö(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 11-03 D (Room.203) 11:30~12:00 Proper response to medical assault and verbal abuse ÃÖżö(°æÈñÀÇ´ë)
½Ä»ç 11-03 B,D,E 12:30~13:00 ½Ä»ç ()
±³À°½Ã°£ 11-03 C (Room.202) 13:00~13:05 Remodeling of tumor microenvironment in lung metastatic sites by oncolytic vaccinia virus in pulmonary metastatic orthotopic renal cell carcinoma murine model ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø)
±³À°½Ã°£ 11-03 C (Room.202) 13:05~13:10 BRCA1/2 and ATM mutated metastatic prostate cancers may present with low serum PSA ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 13:10~13:15 VNTR polymorphism in the breakpoint region of ABL1 and bladder cancer ±èų²(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 13:15~13:20 Optical Genome Mapping Identifies Complex Genomic Rearrangement in Prostate Cancer Needle Biopsy Sample ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 13:20~13:25 Genomic features associated with therapeutic responsiveness of immune checkpoint blockades in patients with metastatic renal cell carcinoma ±èÁرÔ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 13:25~13:30 Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma ±¸¿µ¶õ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 13:30~13:35 Development and Validation of a Method for Detection of Circulating Tumour DNA in Muscle-Invasive Bladder Cancer Ruchira Nandurkar(Eastern Health Clinical School, Monash University, Australia1Eastern Health, Australia)
±³À°½Ã°£ 11-03 C (Room.202) 13:35~13:40 Carboxyl esterase-TRAIL expressing human adipose stem cells inhibit tumor growth in castration resistant prostate cancer bearing mice with less toxicity. ¼ÛÀ±¼·(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 13:40~13:45 The anti-metastatic effect of PDK4 inhibition in bladder cancer via Akt, ERK, and JNK signaling pathway. ÀÌ»óÈñ(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 13:45~13:50 RPL9 gene expression could predict the BCG response in non-muscle invasive bladder cancer patients ¹ÚÇö¹Ì(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 13:50~13:55 Urinary exosome microRNA signatures as a non-invasive prognostic biomarker for prostate cancer ½Åµ¿È£(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 13:55~14:00 Åä·Ð ()
±³À°½Ã°£ 11-03 C (Room.202) 14:00~14:05 Adipose-derived stem cells therapy in a rat model with urethral stricture/fibrosis °í±¤Áø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:05~14:10 Therapeutic efficacy of human embryonic stem cell-derived multipotent stem cells in diabetic detrusor underactivity: A preclinical study ·ùä¹Î(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:10~14:15 A Novel Therapeutic Strategy using Ultrasound Mediated-Microbubbles Drug Delivery System to treat Prostatic Hyperplasia ÀÌÀç±Ù(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:15~14:20 Enhanced efficacy of Wharton¡¯s jelly mesenchymal stem cells and their derived Extracellular vesicles in interstitial cystitis/bladder pain syndrome mice model treatment ±è¾Æ¶÷(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:20~14:25 A preclinical study of human embryonic stem cell-derived mesenchymal stem cells for treating detrusor underactivity by chronic bladder ischemia ½ÅÁ¤Çö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:25~14:30 Therapeutic effects of Primed Fresh OCT4 enriched mesenchymal stem cells in radiation cystitis mouse model ½ÅÁ¤Çö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:30~14:35 Metformin and Sildenafil Protects against Ischemia/Reperfusion-Induced Injury in Rat Urinary Bladders ÀÌÀç±Ù(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:35~14:40 Extracorporeal Shockwave Therapy Improves CP/CPPS by Down-regulating NLPR3 Inflammasome in a Prostatitis Rat Model ½Åµ¿È£(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:40~14:45 Differentially expressed mRNA in streptozotocin induced diabetic bladder using QuantSeq next generation sequencing ¼ÛÀ±¼·(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:45~14:50 First 3D vascular map of a rabbit urethra visualized by a photoacoustic catheter probe ÇÏÀ±¼®(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:50~14:55 Development of an automatic interpretation algorithm for uroflowmetry results: application of artificial intelligence ¿¹Ã¢Èñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 14:55~15:00 Åä·Ð ()
±³À°½Ã°£ 11-03 C (Room.202) 15:00~15:05 Anticancer effect of GLUT1 targeting agent against kidney cancer ÀÌÁö¿µ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:05~15:10 Systemic effects of oncolytic vaccinia virus in prevention and regression of lung metastasis in renal cell carcinoma ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø)
±³À°½Ã°£ 11-03 C (Room.202) 15:10~15:15 Regulation of hippo-pathway via epigenetic control in RCC È«¼ºÈÖ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:15~15:20 Inhibition of metabolic symbiosis by AUBP in RCC Çϳª°æ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:20~15:25 The combination of sunitinib and metformin promotes autophagy of RCC Çϳª°æ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:25~15:30 Metformin enhanced everolimus sensitivity by regulating the mitochondrial dynamic in RCC. ȲÇöÁö(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:30~15:35 Ginsenoside Rh2 strengthens cell cycle arrest by sunitinib in renal cell carcinoma ȲÇöÁö(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:35~15:40 Tubular damage marker is a predictive factor for distinguishing pathological upstaged renal cell carcinoma ÇÑÀåÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:40~15:45 Lymphocyte-activation gene 3 (LAG-3) + tumor infiltrating immune cells in clear cell renal cell carcinoma: Clinical correlates and association with PD-L1 + tumors ÀÌÂùÈ£(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:45~15:50 Deep learning-based metastasis prediction model for kidney cancer patients after nephrectomy ±èµ¿¿ø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:50~15:55 Artificial Intelligence Model Predicts Postoperative Renal Function and Acute Kidney Injury Severity ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 15:55~16:00 Åä·Ð ()
±³À°½Ã°£ 11-03 C (Room.202) 16:00~16:05 Liposome-Encapsulated Bacillus Calmette–Guérin Cell Wall Skeleton Enhances Antitumor Efficiency for Bladder Cancer In Vitro and In Vivo study ½ÉÀçÇå(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:05~16:10 Neoadjuvant versus adjuvant chemotherapy in bladder cancer: A nationwide cohort Study ÇãűÔ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:10~16:15 Comparison of Functional and Oncological Outcomes between Reproductive Organ-Sparing Radical Cystectomy and Standard Radical Cystectomy in Women: A Retrospective Study ¹ÚÀç¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:15~16:20 Predicting factor analysis of postoperative complications after robot-assisted radical cystectomy (RARC) ¿¹Ã¢Èñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:20~16:25 Expression of VISTA on tumor‑infiltrating immune cells correlated with short intravesical recurrence in non‑muscle‑invasive bladder cancer ¼¿øÀÍ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:25~16:30 Prognostic value of the endothelial activation and stress index in upper tract urothelial cancer patients who underwent radical nephroureterectomy. ±¸Áø¼®(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:30~16:35 Acidic urine might confer optimized tumor microenvironment for bladder cancer progression ÇÑÀåÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:35~16:40 Impact of Preoperative Chemotherapy on Pathologic Nodal Status in Muscle-Invasive Bladder Cancer: Optimal Lymphadenectomy in the Preoperative Chemotherapy Era ÀÌ¿øö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:40~16:45 The effect of antithrombotic therapy on T stage and grade of bladder cancer at the time of diagnosis ±è°æȯ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:45~16:50 Catheter-associated urinary tract infections in bladder cancer patients undergone radical cystectomy Źü½Ä(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:50~16:55 Clinical determinant of early or later recurrence of pTa bladder cancer following TURB Á¤½Âȯ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-03 C (Room.202) 16:55~17:00 Åä·Ð ()